StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex gross margin

Gross margin is gross profit as a percentage of revenue.

Vaccinex's gross margin for the twelve months ending Dec 31, 2020 was 99.7%. For fiscal 2020 it was 99.7%, against 62.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 202099.7%+37.7
FY2019Dec 31, 201962.0%+104.6
FY2018Dec 31, 2018-42.7%+35.1
FY2017Dec 31, 2017-77.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 202099.7%+154.8
Q3 FY2019Sep 30, 201998.0%+122.3
Q2 FY2019Jun 30, 201936.0%+131.2
Q1 FY2019Mar 31, 2019-86.2%−69.7
Q4 FY2018Dec 31, 2018-55.2%–
Q3 FY2018Sep 30, 2018-24.2%–
Q2 FY2018Jun 30, 2018-95.2%–
Q1 FY2018Mar 31, 2018-16.5%–

More Vaccinex figures

See a number that looks wrong?